Plasma Adhesion and Inflammation Markers: Asymmetrical Dimethyl-L-Arginine and Secretory Phospholipase A2 Concentrations before and after Laparoscopic Gastric Banding in Morbidly Obese Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The aim of this study was to examine the relationship between subclinical inflammation and weight loss by laparoscopic adjustable gastric banding (LAGB).
Plasma concentrations of intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), sensitive C-Reactive Protein (sCRP), asymmetrical dimethyl-L-arginine (ADMA), Secretory Phospholipase A2 (sPLA2), and metabolic markers, such as homeostatic model assessment –insulin resistance (HOMA-IR) and body mass index (BMI) were determined in morbidly obese patients (n––8, BMI 48.6 ±–.7 kg/m2) at baseline and 1 month after operations. Baseline levels in patients were also compared with age-matched controls (n––0, BMI 21.3 ±–.8 kg/m2). Plasma ICAM-1,VCAM, sCRP and ADMA, and sPLA2 concentrations were determined by enzyme-linked immunoassay methods and colorimetric method, respectively.
Plasma sCRP, ICAM-1, ADMA and sPLA2 concentrations and HOMA-IR were significantly higher in morbidly obese patients than in controls (for each, P–lt;–.01). Plasma VCAM-1 concentration was not changed in obese patients. HOMA-IR was significantly correlated with ICAM-1, ADMA and sPLA2 in the obese group at baseline (for each, P–lt;–.01). There was a significant correlation between plasma sCRP and plasma glucose,VCAM-1, ICAM-1, ADMA and sPLA2 concentrations (for each, P–lt;–.01). 1 month after LAGB, mean body weight loss was 13.2 ±–.3 kg, and plasma sCRP and ADMA concentrations and HOMA-IR and BMI were significantly decreased (for each, P–lt;–.01). However, these levels cannot be decreased to the levels of the controls.
Obesity and insulin resistance appear to be associated with low-grade inflammation and endothelial dysfunction. Insulin resistance and endothelial dysfunction were improved by weight loss after LAGB.
- Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168–5. CrossRef
- Vendrell J, Broch M, Vilarrasa N et.al Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962–1. CrossRef
- Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983–2. CrossRef
- Cooke JP. ADMA: its role in vascular disease. Vasc Med 2005; 10 (Suppl 1): S11–S17. CrossRef
- Mulvihill NT, Foley JB, Crean P et al. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur Heart J 2002; 23: 1569–4. CrossRef
- Szmitko PE, Wang CH, Weisel RD et al. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation 2003; 108: 2041–. CrossRef
- Kougias P, Chai H, Lin PH et al. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006; 12: RA5–RA16.
- Ballantyne CM, Hoogeveen RC, Bang H et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004; 109: 837–2. CrossRef
- Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195–00. CrossRef
- Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Draft Statement. Obes Surg 1991; 1: 257–6.
- Eisenberg D, Duffy AJ, Bell RL. Update on obesity surgery. World J Gastroenterol 2006; 12: 3196–03.
- Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med 2005; 10 (Suppl 1): S35–S43. CrossRef
- Konukoglu D, Serin O, Turhan MS. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res 2006; 37: 602–. CrossRef
- Boger RH, Bode-Boger SM, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842–.
- McLaughlin T, Stuhlinger M, Lamendola C et al. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab 2006; 91: 1896–00. CrossRef
- Stuhlinger MC, Abbasi F, Chu JW et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287: 1420–. CrossRef
- Jiang JL, Jiang DJ, Tang YH et al. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Acta Pharmacol Sin 2004; 25: 893–01.
- Tietge UJ, Pratico D, Ding T et al. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress. J Lipid Res 2005; 46: 1604–4. CrossRef
- Jia SJ, Jiang DJ, Hu CP et al. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol 2006; 44: 143–. CrossRef
- Zhang J, Rui YC, Yang PY et al. C-reactive protein induced expression of adhesion molecules in cultured cerebral microvascular endothelial cells. Life Sci 2006; 78: 2983–. CrossRef
- Pearson TA, Mensah GA, Alexander RW et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499–11. CrossRef
- Albert MA, Ridker PM. Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis. Rev Cardiovasc Med 2004; 5 (Suppl 3): S22–S27.
- Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804–. CrossRef
- Vazquez LA, Pazos F, Berrazueta JR et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005; 90: 316–2. CrossRef
- Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Endothelial function and weight loss in obese humans. Obes Surg 2005; 15: 1055–0. CrossRef
- Krzyzanowska K, Mittermayer F, Kopp HP et al. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 2004; 89: 6277–1. CrossRef
- Kopp HP, Kopp CW, Festa A et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042–. CrossRef
- Gasteyger C, Suter M, Calmes JM et al. Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding. Obes Surg 2006; 16: 243–0. CrossRef
- Cottam DR, Schaefer PA, Shaftan GW et al. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 2002; 12: 335–2. CrossRef
- Pontiroli AE, Pizzocri P, Koprivec D et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 2004; 150: 195–00. CrossRef
- Hanusch-Enserer U, Cauza E, Spak M et al. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 2004; 12: 284–1. CrossRef
- Uzun H, Zengin K, Taskin M et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 2004; 14: 659–5. CrossRef
- Plasma Adhesion and Inflammation Markers: Asymmetrical Dimethyl-L-Arginine and Secretory Phospholipase A2 Concentrations before and after Laparoscopic Gastric Banding in Morbidly Obese Patients
Volume 17, Issue 5 , pp 672-678
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Morbid obesity
- endothelial dysfunction
- laparoscopic adjustable gastric banding
- Industry Sectors
- Author Affiliations
- 1. Istanbul University, Cerrahpasa Medical Faculty, Department of Biochemistry, Istanbul, Turkey
- 3. Cerrahpa_a Tip Fakültesi, Temel Bilimler-Biokimya Anabilim Dali, 34303, Cerrahpa_a-, Istanbul, Turkey
- 2. Istanbul University, Cerrahpasa Medical Faculty, Department of Surgery, Istanbul, Turkey